{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T04:04:27Z","timestamp":1750565067670,"version":"3.41.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Primary retroperitoneal tumors are rare. Of these, primary retroperitoneal serous carcinoma is extremely rare, with only 15 cases having been reported. A 62-year-old woman presented with abdominal bloating. PET\/CT demonstrated 2 tumors showing increased FDG uptake lateral and medial to the right common iliac vessels, without other abnormal uptake. A laparotomy revealed no ascites or abnormalities except a myomatous uterus in the peritoneal cavity. After surgical removal of these retroperitoneal tumors, the patient received adjuvant paclitaxel\/carboplatin chemotherapy and remained well for 80 months. This case points to the significance of <jats:sup>18<\/jats:sup>F-FDG PET\/CT in determining the nature of retroperitoneal tumors.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004692","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T18:00:58Z","timestamp":1683828058000},"page":"625-626","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["FDG PET\/CT in Primary Retroperitoneal Serous Carcinoma"],"prefix":"10.1097","volume":"48","author":[{"given":"Isao","family":"Otsuka","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Honma","sequence":"additional","affiliation":[{"name":"Anatomic Pathology, Kameda Medical Center, Kamogawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejogrb.2018.10.035","article-title":"Development and rapid growth of retroperitoneal leiomyoma during carboplatin\/paclitaxel chemotherapy in an ovarian cancer patient","volume":"231","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/ajcp\/79.5.633","article-title":"Papillary serous carcinoma of the retroperitoneum","volume":"79","year":"1983","journal-title":"Am J Clin Pathol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0720-048X(93)90046-P","article-title":"Primary retroperitoneal serous cystadenocarcinoma of \u2018ovarian type\u2019: US and CT findings","volume":"17","year":"1993","journal-title":"Eur J Radiol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0009-9260(98)80222-5","article-title":"Case report: serous cystadenocarcinoma of the retroperitoneum: CT and sonographic appearance","volume":"53","year":"1998","journal-title":"Clin Radiol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1525-1438.1999.09910.x","article-title":"Primary serous adenocarcinoma of the retroperitoneum with a response to platinum-based chemotherapy: a case report","volume":"9","year":"1999","journal-title":"Int J Gynecol Cancer"},{"key":"bib6-20250621","first-page":"B71","article-title":"Primary serous papillary carcinoma of the retroperitoneum: magnetic resonance imaging findings with pathologic correlation","volume":"51","year":"2007","journal-title":"Australas Radiol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1442-2042.2011.02875.x","article-title":"A case of primary retroperitoneal serous adenocarcinoma","volume":"18","year":"2011","journal-title":"Int J Urol"},{"key":"bib8-20250621","first-page":"1277","article-title":"A case of primary retroperitoneal serous adenocarcinoma and literature review","volume":"2","year":"2017","journal-title":"Ann Clin Case Rep"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s13691-017-0296-8","article-title":"Serous adenocarcinoma of retroperitoneum: a case report","volume":"6","year":"2017","journal-title":"Int Cancer Conf J"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.2169\/internalmedicine.0591-17","article-title":"Resection for primary retroperitoneal serous adenocarcinoma and liver metastasis","volume":"57","year":"2018","journal-title":"Intern Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1186\/s12885-019-5934-4","article-title":"Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous adenocarcinoma: a case report and literature review","volume":"19","year":"2019","journal-title":"BMC Cancer"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00404-003-0550-5","article-title":"A primary retroperitoneal serous cystadenocarcinoma with clinically aggressive behavior","volume":"270","year":"2004","journal-title":"Arch Gynecol Obstet"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s10147-008-0827-6","article-title":"Serous adenocarcinoma of the retroperitoneum, as a type of multifocal M\u00fcllerian carcinoma","volume":"14","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13000-019-0795-3","article-title":"Concurrent isolated retroperitoneal HGSC and STIC defined by somatic mutation analysis: a case report","volume":"14","year":"2019","journal-title":"Diagn Pathol"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/ijc.IJC_528_19","article-title":"Primary retroperitoneal serous adenocarcinoma: a case report of rare malignancy with literature review","volume":"58","year":"2021","journal-title":"Indian J Cancer"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12880-021-00613-4","article-title":"Added value of contrast-enhanced ultrasound (CEUS) in the diagnosis of primary retroperitoneal serous adenocarcinoma: a case report","volume":"21","year":"2021","journal-title":"BMC Med Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:05:10Z","timestamp":1750532710000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004692","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2023,5,11]]}}}